Outset Medical Inc (OM)
0.6131
+0.09
(+16.12%)
USD |
NASDAQ |
Sep 27, 16:00
0.61
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Research and Development Expense (TTM): 50.98M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 50.98M |
March 31, 2024 | 56.15M |
December 31, 2023 | 57.31M |
September 30, 2023 | 56.22M |
June 30, 2023 | 53.20M |
March 31, 2023 | 51.82M |
December 31, 2022 | 48.86M |
September 30, 2022 | 48.82M |
June 30, 2022 | 45.49M |
Date | Value |
---|---|
March 31, 2022 | 40.00M |
December 31, 2021 | 36.74M |
September 30, 2021 | 33.12M |
June 30, 2021 | 32.56M |
March 31, 2021 | 30.58M |
December 31, 2020 | 28.85M |
September 30, 2020 | 27.70M |
June 30, 2020 | 24.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
24.23M
Minimum
Jun 2020
57.31M
Maximum
Dec 2023
42.51M
Average
45.49M
Median
Jun 2022
Research and Development Expense (TTM) Benchmarks
Abbott Laboratories | 2.754B |
Baxter International Inc | 687.00M |
ICU Medical Inc | 88.51M |
Paragon 28 Inc | 30.01M |
Perspective Therapeutics Inc | 28.53M |